INFLAMMATORY BOWEL DISEASE (IBD)
Clinical trials for INFLAMMATORY BOWEL DISEASE (IBD) explained in plain language.
Never miss a new study
Get alerted when new INFLAMMATORY BOWEL DISEASE (IBD) trials appear
Sign up with your email to follow new studies for INFLAMMATORY BOWEL DISEASE (IBD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New tool aims to keep IBD patients out of the ER
Disease control ENROLLING_BY_INVITATIONThis study tests an automated tool that uses patient risk levels to remind people with inflammatory bowel disease (IBD) when they need follow-up appointments. About 1,000 adults with IBD will be randomly assigned to use the tool or receive usual care. The goal is to see if the to…
Matched conditions: INFLAMMATORY BOWEL DISEASE (IBD)
Phase: NA • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated May 17, 2026 00:28 UTC
-
Gut bacteria booster aims to calm IBD inflammation
Disease control OngoingThis study tests whether a specially selected probiotic called LR607 can help control inflammation in people with mild-to-moderate ulcerative colitis (a type of IBD). The probiotic is designed to boost a natural gut pathway (NOD2) that is often faulty in IBD. About 300 participan…
Matched conditions: INFLAMMATORY BOWEL DISEASE (IBD)
Phase: NA • Sponsor: Shenzhen Hospital of Southern Medical University • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Exercise program aims to boost energy and quality of life in children with IBD
Symptom relief OngoingThis study looks at whether a personalized 24-week exercise program can help children with inflammatory bowel disease (IBD) feel less tired and improve their quality of life. About 70 kids with IBD will be split into two groups based on their current exercise habits and will wear…
Matched conditions: INFLAMMATORY BOWEL DISEASE (IBD)
Phase: NA • Sponsor: Universiteit Antwerpen • Aim: Symptom relief
Last updated May 17, 2026 00:41 UTC
-
IBD patients switch to home shots: new study checks results
Knowledge-focused OngoingThis study reviews medical records of 120 adults with Crohn's disease or ulcerative colitis who switched from intravenous to subcutaneous (under-the-skin) vedolizumab. Researchers want to see if patients stay in remission and what dosing patterns they use. No new treatments are g…
Matched conditions: INFLAMMATORY BOWEL DISEASE (IBD)
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated May 11, 2026 20:48 UTC
-
Doctor education aims to boost use of cheaper biologic drugs
Knowledge-focused OngoingThis study tests whether offering doctors one-on-one educational meetings about biosimilar medications leads them to prescribe more biosimilars instead of the original brand-name drugs. About 1,325 clinicians who prescribe adalimumab will be randomly offered either an in-person o…
Matched conditions: INFLAMMATORY BOWEL DISEASE (IBD)
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 07, 2026 18:39 UTC